|
Invited Speakers:
|
|
GEORGE Q. MILLS, MD
Director, Medical Imaging and Radiopharmaceutical
Drug Products, Office of New Drugs, CDER, FDAADEBAYO LANIYONU, PHD
Supervisory Pharmacologist, Office of Oncology Drug
Products, Office of New Drugs, CDER, FDA RAVI S. HARAPANHALLI
Supervisory Interdisciplinary Scientist, CMC, Office of
New Drug Quality Assessment, CDER, FDA DAVID JACOBSON-KRAM, PHD
Associate Director for Pharmacology and Toxicology,
Office of New Drugs, CDER, FDA MONICA E. CAPHART
Senior Compliance Officer, Office of Compliance,
CDER, FDA
|
|